Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects

Inclusion Criteria: * Health male subjects, age between 18-45 years. * BMI between 19 and 26 kg/m2 . * Signed informed consent. Exclusion Criteria: * Abnormal results in physical examination、laboratory tests、X-ray、abdominal ultrasound、echocardiography have clinical significance. * Abnormal platelet counts or platelet aggregation has clinical significance. * Abnormal troponin examination has clinical significance. * Abnormal ophthalmic examination has clinical significance. * Hepatitis B surface antigen, hepatitis C antibody, syphilis antibody or HIV antibody is positive. * Those who have a history of allergies to test drugs or similar drugs. * Those who have undergone surgery within 6 months prior to the trial . * Those who took any drug within 14 days before the test (including Chinese herbal medicine). * Any drug that inhibits or induces liver drug metabolism within 30 days before the test. * Subjects who have participated in other clinical trial within the 3 months prior to study entry. * One or more non-pharmacological contraceptive measures cannot be used during the trial or it is planned to have birth within one year.